ECOR - electroCore, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Rockaway,
United States
Type: Equity
ECOR price evolution
ECOR
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $10.55 | $8.1 | $10.58 | |
| Short term investments | $3.93 | |||
| Net receivables | $0.55 | $0.54 | $0.47 | $0.72 |
| Inventory | $1.96 | $2.58 | $2.51 | $2.77 |
| Total current assets | $16.78 | $17.96 | $11.71 | $14.29 |
| Long term investments | ||||
| Property, plant & equipment | $3.9 | $3.96 | $1.73 | $0.71 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $4.4 | $2.18 | $1.81 | |
| Total investments | $3.93 | |||
| Total assets | $21.05 | $22.36 | $13.89 | $16.1 |
| Current liabilities | ||||
| Accounts payable | $1.24 | $1.46 | $2.32 | $2.16 |
| Deferred revenue | ||||
| Short long term debt | $0.34 | $0.09 | $0.09 | |
| Total current liabilities | $7.91 | $7.25 | $7.83 | $8.12 |
| Long term debt | $3.63 | $1.57 | $0.54 | |
| Total noncurrent liabilities | $3.63 | $1.57 | $0.54 | |
| Total debt | $3.97 | $1.66 | $0.63 | |
| Total liabilities | $11.59 | $10.88 | $9.39 | $8.66 |
| Shareholders' equity | ||||
| Retained earnings | -$173.86 | -$171.37 | -$168.71 | -$165.2 |
| Other shareholder equity | $0.18 | $0.04 | $0.01 | -$0.06 |
| Total shareholder equity | $11.47 | $4.5 | $7.44 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $10.58 | $17.96 | $34.69 | $4.24 |
| Short term investments | $18.39 | |||
| Net receivables | $0.72 | $0.4 | $0.44 | $0.27 |
| Inventory | $2.77 | $1.98 | $5.3 | $5.74 |
| Total current assets | $14.29 | $21.17 | $37.54 | $25.06 |
| Long term investments | ||||
| Property, plant & equipment | $0.71 | $0.61 | $0.76 | $0.76 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $1.81 | $3.58 | $5.29 | $6.45 |
| Total investments | $18.39 | |||
| Total assets | $16.1 | $24.76 | $42.83 | $31.52 |
| Current liabilities | ||||
| Accounts payable | $2.16 | $2.13 | $1.54 | $2.08 |
| Deferred revenue | ||||
| Short long term debt | $0.09 | $0.07 | $0.06 | $1.01 |
| Total current liabilities | $8.12 | $7.04 | $5.49 | $5.89 |
| Long term debt | $0.54 | $0.63 | $0.7 | $1.98 |
| Total noncurrent liabilities | $0.54 | $0.63 | $0.7 | $1.98 |
| Total debt | $0.63 | $0.7 | $0.76 | $2.99 |
| Total liabilities | $8.66 | $7.67 | $6.18 | $7.87 |
| Shareholders' equity | ||||
| Retained earnings | -$165.2 | -$146.37 | -$124.21 | -$106.99 |
| Other shareholder equity | -$0.06 | -$0.07 | $0.01 | -$0.25 |
| Total shareholder equity | $7.44 | $17.09 | $36.65 | $23.01 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $6.14 | $5.44 | $5.19 | |
| Cost of revenue | $0.84 | $0.89 | $1.1 | |
| Gross Profit | $5.3 | $4.55 | $4.09 | |
| Operating activities | ||||
| Research & development | $0.64 | $0.4 | $1.11 | |
| Selling, general & administrative | $7.26 | $8.01 | $6.94 | |
| Total operating expenses | $7.89 | $8.4 | $8.05 | |
| Operating income | -$2.59 | -$3.85 | -$3.96 | |
| Income from continuing operations | ||||
| EBIT | -$2.65 | -$3.63 | -$4.01 | |
| Income tax expense | -$0.12 | $0.03 | ||
| Interest expense | ||||
| Net income | ||||
| Net income | -$2.65 | -$3.51 | -$4.03 | |
| Income (for common shares) | -$2.65 | -$3.51 | -$4.03 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $16.03 | $8.59 | $5.45 | $3.5 |
| Cost of revenue | $2.8 | $1.62 | $1.39 | $1.74 |
| Gross Profit | $13.23 | $6.98 | $4.07 | $1.76 |
| Operating activities | ||||
| Research & development | $5.32 | $5.52 | $2.54 | $4.2 |
| Selling, general & administrative | $27.17 | $24.33 | $21.57 | $21.84 |
| Total operating expenses | $32.49 | $29.85 | $24.11 | $26.51 |
| Operating income | -$19.27 | -$22.87 | -$20.04 | -$24.75 |
| Income from continuing operations | ||||
| EBIT | -$19.02 | -$22.59 | -$18.07 | -$24.68 |
| Income tax expense | -$0.19 | -$0.43 | -$0.85 | -$1.17 |
| Interest expense | ||||
| Net income | ||||
| Net income | -$18.83 | -$22.16 | -$17.22 | -$23.51 |
| Income (for common shares) | -$18.83 | -$22.16 | -$17.22 | -$23.51 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$2.65 | -$3.51 | -$4.03 | |
| Operating activities | ||||
| Depreciation | $0.23 | $0.22 | $0.29 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.47 | $0.48 | $0.4 | |
| Total cash flows from operations | -$1.77 | -$2.56 | -$3.12 | |
| Investing activities | ||||
| Capital expenditures | -$0.04 | |||
| Investments | ||||
| Total cash flows from investing | -$8.02 | -$0.04 | ||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $8.07 | |||
| Effect of exchange rate | $0.24 | $0.03 | $0.08 | $0.04 |
| Change in cash and equivalents | -$5.4 | $2.45 | -$2.48 | -$3.13 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$18.83 | -$22.16 | -$17.22 | -$23.51 |
| Operating activities | ||||
| Depreciation | $1.02 | $0.6 | $0.44 | $0.77 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.7 | $2.68 | $3.3 | $3.27 |
| Total cash flows from operations | -$14.67 | -$16.64 | -$13.63 | -$20.1 |
| Investing activities | ||||
| Capital expenditures | -$0.21 | |||
| Investments | $18.22 | -$7.96 | ||
| Total cash flows from investing | -$0.21 | $18.22 | -$7.96 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $8.14 | $25.68 | $17.49 | |
| Net borrowings | $1.46 | |||
| Total cash flows from financing | $7.49 | $25.68 | $18.95 | |
| Effect of exchange rate | $0.01 | -$0.08 | $0.18 | -$0.21 |
| Change in cash and equivalents | -$7.38 | -$16.73 | $30.45 | -$9.32 |
News
Fundamentals
| Market cap | $36.83M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 6.51M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.16 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.12 |
| Quick ratio | 1.87 |